Get the Stockscreener App
46.66
1.02%
-0.48
After Hours:
47.00
0.34
+0.73%
Scholar Rock Holding Corp stock is traded at $46.66, with a volume of 795.94K.
It is down -1.02% in the last 24 hours and up +7.12% over the past month.
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
See More
Previous Close:
$47.14
Open:
$47.14
24h Volume:
795.94K
Relative Volume:
0.58
Market Cap:
$4.76B
Revenue:
$47.30M
Net Income/Loss:
$-225.97M
P/E Ratio:
-19.86
EPS:
-2.35
Net Cash Flow:
$-188.86M
1W Performance:
+4.97%
1M Performance:
+7.12%
6M Performance:
+44.91%
1Y Performance:
+25.46%
1-Day Range:
$45.76
$48.09
1-Week Range:
$44.73
$48.29
52-Week Range:
$22.71
$49.82
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Name
Scholar Rock Holding Corp
Sector
Industry
Phone
857-259-3860
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
46.66 | 4.81B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Citigroup | Buy |
| Nov-18-25 | Initiated | Wolfe Research | Outperform |
| Oct-09-25 | Initiated | BofA Securities | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-15-25 | Initiated | Leerink Partners | Outperform |
| Aug-21-25 | Resumed | Jefferies | Buy |
| Jul-30-25 | Resumed | Raymond James | Strong Buy |
| Jul-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-26-24 | Reiterated | H.C. Wainwright | Buy |
| Oct-07-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-24 | Initiated | Raymond James | Strong Buy |
| Oct-25-23 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Overweight |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Jul-12-22 | Initiated | Truist | Buy |
| Mar-23-22 | Initiated | H.C. Wainwright | Buy |
| Dec-22-21 | Downgrade | Jefferies | Buy → Hold |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Jan-11-21 | Initiated | Credit Suisse | Outperform |
| Jan-06-21 | Initiated | JP Morgan | Overweight |
| Mar-12-20 | Initiated | Robert W. Baird | Outperform |
View All
Scholar Rock Holding Corp Stock (SRRK) Latest News
Candriam S.C.A. Cuts Stock Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock schedules March 3 call on 2025 financial results - Stock Titan
Is Scholar Rock (SRRK) Pricing Reflect Its Strong Multi Year Share Performance Gains - simplywall.st
Scholar Rock Insider Sales Coincide With Key Apitegromab Launch Decisions - simplywall.st
Scholar Rock stock hits 52-week high at $48.46 By Investing.com - Investing.com Nigeria
Scholar Rock stock hits 52-week high at $48.46 - Investing.com
Scholar Rock (NASDAQ:SRRK) Reaches New 12-Month HighHere's Why - MarketBeat
A Look At Scholar Rock (SRRK) Valuation After A Strong 3 Month Share Price Return - simplywall.st
Scholar Rock Holding (SRRK) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 - The Motley Fool
Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026 - The Motley Fool
Profit Recap: What makes Scholar Rock Holding Corporation stock attractive todayRate Cut & AI Forecast Swing Trade Picks - baoquankhu1.vn
Nan Fung Trinity HK Ltd. Invests $1.40 Million in Scholar Rock Holding Corporation $SRRK - MarketBeat
Federated Hermes Inc. Has $29.81 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Is Scholar Rock Holding (NASDAQ:SRRK) Using Debt Sensibly? - 富途牛牛
Scholar Rock FY2027 EPS Forecast Raised by HC Wainwright - MarketBeat
HC Wainwright Predicts Scholar Rock FY2030 Earnings - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Has $5.95 Million Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
EFG Asset Management North America Corp. Grows Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock stock price target raised to $58 from $44 at H.C. Wainwright - Investing.com Nigeria
SRRK: HC Wainwright Raises Price Target to $58, Maintains Buy Ra - GuruFocus
Insider Sell: Mo Qatanani Sells Shares of Scholar Rock Holding C - GuruFocus
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 14,898 Shares of Stock - MarketBeat
Marantz Jing L., chief medical officer at Scholar Rock, sells $257,881 in stock - Investing.com UK
Scholar Rock CSO Qatanani sells $373k in shares By Investing.com - Investing.com Australia
Caryn Parlavecchio, CHRO of Scholar Rock, sells $293k in shares - Investing.com Canada
Caryn Parlavecchio, CHRO of Scholar Rock, sells $293k in shares By Investing.com - Investing.com South Africa
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 6,600 Shares of Stock - MarketBeat
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 8,406 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) General Counsel Junlin Ho Sells 8,016 Shares - MarketBeat
Ho Junlin, general counsel of Scholar Rock, sells $356k in SRRK - Investing.com UK
Ho Junlin, general counsel of Scholar Rock, sells $356k in SRRK By Investing.com - Investing.com South Africa
Scholar Rock CSO Qatanani sells $373k in shares - Investing.com
Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech with 9.76% Potential Upside - DirectorsTalk Interviews
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Can Scholar Rock Holding Corporation stock sustain revenue growthEarnings Overview Summary & Verified Momentum Stock Watchlist - bollywoodhelpline.com
Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 13,112 Shares of Stock - MarketBeat
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock By Investing.com - Investing.com Nigeria
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Two new Scholar Rock hires receive 35,200-share equity grant package - Stock Titan
Scholar Rock Holding Insider Sold Shares Worth $2,453,115, According to a Recent SEC Filing - marketscreener.com
Scholar Rock (SRRK) COO Woods sells $715k in stock By Investing.com - Investing.com Australia
Vaishnaw, Scholar Rock president, sells $872k in shares By Investing.com - Investing.com Nigeria
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock - Investing.com Australia
Insider Selling: Scholar Rock (NASDAQ:SRRK) COO Sells 16,746 Shares of Stock - MarketBeat
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 20,438 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) CFO Vikas Sinha Sells 16,755 Shares - MarketBeat
Scholar Rock Holding Corp Stock (SRRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):